Parabolic Drugs has reported results for first quarter ended June 30, 2012.
The company has reported a fall of 35.70% in its net profit at Rs 9.76 crore for the quarter under review as compared to a net profit of Rs 15.18 crore for the same quarter in the previous year. However, the total income from operation of the company has increased by 62.72% at Rs 307.32 crore for Q1FY13 as compared Rs 188.87 crore for the corresponding quarter previous year.
Parabolic Drugs has recommend dividend of Rs 0.25 per share on fully paid equity shares of the company for the year 2011-2012.
